Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-17
DOI
10.3389/fonc.2021.642229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Functional Diversity of p53 in Human and Wild Animals
- (2019) Yi Li et al. Frontiers in Endocrinology
- Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia
- (2019) Jinghan Wang et al. Journal of Translational Medicine
- Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle
- (2019) Koen H. G. Verschueren et al. NATURE
- NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
- (2019) Deborah K. Armstrong et al. Journal of the National Comprehensive Cancer Network
- Overexpression of ATP citrate lyase in renal cell carcinoma tissues and its effect on the human renal carcinoma cells in�vitro
- (2018) Lichen Teng et al. Oncology Letters
- Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism
- (2016) Supriya Shah et al. Oncotarget
- ATP Citrate Lyase (ACLY): A Promising Target for Cancer Prevention and Treatment
- (2015) Amrita Khwairakpam et al. CURRENT DRUG TARGETS
- Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy
- (2014) Kaniyampadi Snima et al. CURRENT CANCER DRUG TARGETS
- ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway
- (2014) Jong-Hyuk Lee et al. FEBS Journal
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Inhibition of ATP Citrate Lyase Induces an Anticancer Effect via Reactive Oxygen Species
- (2013) Toshiro Migita et al. AMERICAN JOURNAL OF PATHOLOGY
- Pathview: an R/Bioconductor package for pathway-based data integration and visualization
- (2013) Weijun Luo et al. BIOINFORMATICS
- Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells
- (2013) Toshiro Migita et al. INTERNATIONAL JOURNAL OF CANCER
- ATP Citrate Lyase Mediates Resistance of Colorectal Cancer Cells to SN38
- (2013) Y. Zhou et al. MOLECULAR CANCER THERAPEUTICS
- Acetylation Stabilizes ATP-Citrate Lyase to Promote Lipid Biosynthesis and Tumor Growth
- (2013) Ruiting Lin et al. MOLECULAR CELL
- A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells
- (2012) Philippe Icard et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer
- (2012) YU WANG et al. ONCOLOGY REPORTS
- Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein Kinase (MAPK) and Phosphatidylinositol-3-kinase (PI3K)/AKT pathways
- (2011) Jun-ichi Hanai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A Glucose-to-Gene Link
- (2009) J. C. Rathmell et al. SCIENCE
- ATP Citrate Lyase: Activation and Therapeutic Implications in Non-Small Cell Lung Cancer
- (2008) T. Migita et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started